Variant report
Variant | nsv818981 |
---|---|
Chromosome Location | chr13:76610127-76612357 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7997251 | chr13:76610127-76610128 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs149815569 | chr13:76610151-76610152 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115169652 | chr13:76610177-76610178 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs528891370 | chr13:76610220-76610221 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557470623 | chr13:76610238-76610239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575733629 | chr13:76610265-76610266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188406434 | chr13:76610277-76610278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10507843 | chr13:76610290-76610291 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs538328192 | chr13:76610292-76610293 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533167929 | chr13:76610315-76610316 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs376947324 | chr13:76610370-76610371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551259426 | chr13:76610385-76610386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566309082 | chr13:76610404-76610405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34850456 | chr13:76610474-76610475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192816517 | chr13:76610487-76610488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573585447 | chr13:76610516-76610517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184870297 | chr13:76610522-76610523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs10507844 | chr13:76610561-76610562 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs10507845 | chr13:76610578-76610579 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs187748567 | chr13:76610588-76610589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373932869 | chr13:76610614-76610615 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564868988 | chr13:76610616-76610617 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569417639 | chr13:76610681-76610682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9565224 | chr13:76610689-76610690 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs558420868 | chr13:76610690-76610691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573462764 | chr13:76610715-76610716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532183928 | chr13:76610716-76610717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs550677156 | chr13:76610717-76610718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376519091 | chr13:76610723-76610724 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371696782 | chr13:76610728-76610729 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146939260 | chr13:76610748-76610749 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543827376 | chr13:76610762-76610763 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191229314 | chr13:76610765-76610766 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562822217 | chr13:76610766-76610767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs80065706 | chr13:76610773-76610774 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540427122 | chr13:76610788-76610789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10507846 | chr13:76610840-76610841 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs142313045 | chr13:76610939-76610940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527482088 | chr13:76610954-76610955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183726727 | chr13:76610978-76610979 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs370213914 | chr13:76610995-76610996 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561807376 | chr13:76611016-76611017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529306034 | chr13:76611036-76611037 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189313183 | chr13:76611041-76611042 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs55775631 | chr13:76611100-76611101 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539782134 | chr13:76611104-76611105 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192670466 | chr13:76611129-76611130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577455148 | chr13:76611164-76611165 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567071103 | chr13:76611209-76611210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs534347571 | chr13:76611284-76611285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:76608000-76612000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr13:76609000-76610400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
3 | chr13:76609600-76610200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr13:76609600-76611000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr13:76609600-76613800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr13:76609800-76610800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr13:76609800-76610800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr13:76609800-76611000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr13:76610400-76610600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr13:76610400-76611400 | Enhancers | K562 | blood |
11 | chr13:76610400-76611600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
12 | chr13:76610600-76611400 | Enhancers | Brain Anterior Caudate | brain |
13 | chr13:76610600-76611600 | Enhancers | Fetal Lung | lung |
14 | chr13:76610600-76611800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
15 | chr13:76610600-76612400 | Enhancers | Fetal Thymus | thymus |
16 | chr13:76611200-76612000 | Enhancers | Thymus | Thymus |
17 | chr13:76611400-76613000 | Weak transcription | Brain Anterior Caudate | brain |
18 | chr13:76611600-76612200 | Weak transcription | Fetal Lung | lung |
19 | chr13:76611800-76613200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |